Literature DB >> 19255238

Molecular biology and therapeutics in musculoskeletal oncology.

Theresa A Guise1, Regis O'Keefe, R Lor Randall, Richard M Terek.   

Abstract

Mesh：

Year:  2009        PMID： 19255238      PMCID： PMC3346176          DOI： 10.2106/JBJS.I.00012

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  54 in total

1.  In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.

Authors:  Nathaniel S Hwang; Shyni Varghese; H Janice Lee; Zijun Zhang; Zhaohui Ye; Jongwoo Bae; Linzhao Cheng; Jennifer Elisseeff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-18       Impact factor: 11.205

2.  A perivascular origin for mesenchymal stem cells in multiple human organs.

Authors:  Mihaela Crisan; Solomon Yap; Louis Casteilla; Chien-Wen Chen; Mirko Corselli; Tea Soon Park; Gabriella Andriolo; Bin Sun; Bo Zheng; Li Zhang; Cyrille Norotte; Pang-Ning Teng; Jeremy Traas; Rebecca Schugar; Bridget M Deasy; Stephen Badylak; Hans-Jörg Buhring; Jean-Paul Giacobino; Lorenza Lazzari; Johnny Huard; Bruno Péault
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

3.  Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.

Authors:  Xiaolin Wan; Arnulfo Mendoza; Chand Khanna; Lee J Helman
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

4.  Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model.

Authors:  Yi Guo; Elyssa M Rubin; Jun Xie; Xiaolin Zi; Bang H Hoang
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

5.  Maximizing immune responses: the effects of covalent peptide linkage to beta-2-microglobulin.

Authors:  Stephen M Bauer; Marc A Williams; Alan P Howell; Edward Schwarz; Ernest S Smith; Maurice Zauderer
Journal:  Oncol Res       Date:  2008       Impact factor: 5.574

6.  Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.

Authors:  Nadezhda V Koshkina; Chand Khanna; Arnulfo Mendoza; Hui Guan; Lindsey DeLauter; Eugenie S Kleinerman
Journal:  Mol Cancer Res       Date:  2007-10       Impact factor: 5.852

7.  Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan.

Authors:  Robert Nakayama; Yasunori Sato; Mitsuko Masutani; Hideki Ogino; Fumihiko Nakatani; Hirokazu Chuman; Yasuo Beppu; Hideo Morioka; Hiroo Yabe; Hiroshi Hirose; Haruhiko Sugimura; Hiromi Sakamoto; Tsutomu Ohta; Yoshiaki Toyama; Teruhiko Yoshida; Akira Kawai
Journal:  Cancer Sci       Date:  2008-02       Impact factor: 6.716

Review 8.  Novel targets with potential therapeutic applications in osteosarcoma.

Authors:  Chand Khanna
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

9.  2-methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells.

Authors:  Yi-Chin Fong; Wei-Hong Yang; Sheng-Feng Hsu; Horng-Chaung Hsu; Kuo-Fung Tseng; Chin-Jung Hsu; Chun-Yi Lee; Sean P Scully
Journal:  J Orthop Res       Date:  2007-08       Impact factor: 3.494
View more
  12 in total

1.  Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.

Authors:  Liang Bo Zhu; Jian Jiang; Xiao Ping Zhu; Tao Fang Wang; Xuan Yin Chen; Qin Feng Luo; Yong Shu; Zhi Li Liu; Shan Hu Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Celastrol negatively regulates cell invasion and migration ability of human osteosarcoma via downregulation of the PI3K/Akt/NF-κB signaling pathway in vitro.

Authors:  Xiaolong Yu; Qiang Wang; Xin Zhou; Changlin Fu; Ming Cheng; Runsheng Guo; Hucheng Liu; Bin Zhang; Min Dai
Journal:  Oncol Lett       Date:  2016-08-26       Impact factor: 2.967

3.  The molecular pathogenesis of osteosarcoma: a review.

Authors:  Matthew L Broadhead; Jonathan C M Clark; Damian E Myers; Crispin R Dass; Peter F M Choong
Journal:  Sarcoma       Date:  2011-04-13

4.  Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model.

Authors:  M L Broadhead; C R Dass; P F M Choong
Journal:  Br J Cancer       Date:  2011-10-06       Impact factor: 7.640

5.  rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ.

Authors:  Henning Madry; Jagadeesh K Venkatesan; Gertrud Schmitt; Sarah Schetting; Myriam Ekici; Dieter Kohn; Magali Cucchiarini
Journal:  Sarcoma       Date:  2012-05-07

6.  MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo.

Authors:  Kang Yan; Jie Gao; Tongtao Yang; Qiong Ma; Xiuchun Qiu; Qingyu Fan; Baoan Ma
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

7.  Silencing of Eag1 Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF Pathway.

Authors:  Xinyu Wu; Zhida Chen; Wengrong Zeng; Yuanfu Zhong; Qingjun Liu; Jin Wu
Journal:  Biomed Res Int       Date:  2015-12-09       Impact factor: 3.411

Review 8.  The role of the bone microenvironment in skeletal metastasis.

Authors:  Yu Zheng; Hong Zhou; Colin R Dunstan; Robert L Sutherland; Markus J Seibel
Journal:  J Bone Oncol       Date:  2012-12-11       Impact factor: 4.072

9.  Upregulation and biological function of transmembrane protein 119 in osteosarcoma.

Authors:  Zhen-Huan Jiang; Jun Peng; Hui-Lin Yang; Xing-Li Fu; Jin-Zhi Wang; Lei Liu; Jian-Nong Jiang; Yong-Fei Tan; Zhi-Jun Ge
Journal:  Exp Mol Med       Date:  2017-05-12       Impact factor: 8.718

10.  A polymorphism site in the pre‑miR‑34a coding region reduces miR‑34a expression and promotes osteosarcoma cell proliferation and migration.

Authors:  Honglin Lv; Jingfang Pei; Hongtao Liu; Haiyan Wang; Jun Liu
Journal:  Mol Med Rep       Date:  2014-09-18       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.